AVANIR Pharmaceuticals, Inc. is focused on commercializing novel therapeutic products.
|
|
|
New brain imaging could improve PTSD treatments
KGO-TV
Share
   
It is estimated that 20 percent of returning U.S. troops will suffer from Post Traumatic
Stress Disorder or major depression. Research on how best to deal with PTSD is critical as those numbers are expected to grow with more troops coming home from Iraq and Afghanistan. This article reveals some new brain imaging research underway at Pal Alto branch of the U.S. Department of Veterans Affairs.
More
Study shows older people with Vitamin B12 deficiency had lower scores on memory tests
WebMD
Share
Older people with low levels of vitamin B12 may be more prone to age-related memory declines and brain shrinkage. That finding comes from researchers at Chicago's Rush University Medical Center. They found that older people with blood markers associated with vitamin B12 deficiency had the smallest brains and the lowest scores on tests measuring thinking, reasoning, and memory.
More
Lawmakers: CDC to have student concussion protocol
USA Today
Share
As awareness continues to grow about sports-related concussions among student athletes, two New Jersey lawmakers say it's time for schools to start following nationwide protocols governing such injuries. The Centers for Disease Control and Prevention agreed to study and develop national guidelines for managing sports-related concussions for student athletes.
More
Brain cells from your arm?
Columbia Spectator
Share
Columbia researchers have successfully converted human skin cells into brain cells, opening up the possibility of innovative new treatments for Alzheimer's and
other degenerative brain diseases.
More
Brain wiring continues into young
adulthood
Psych Central
Share
New medical research tends to confirm that the human brain does not stop developing in adolescence, but continues well into our 20s, according to investigators
at the University of Alberta.
More
Imaging to lead to better treatment for stroke?
Barchester
Share
New technology could mean there is a bigger window of opportunity to treat some stroke patients than was previously thought, according to scientists. In a report published in journal Lancet Neurology, researchers reviewed stroke studies investigating the use of imaging to measure blood flow to the brain following a stroke. Authors noted that advanced neuroimaging like multi-dimensional brain CT scans and MRIs, could be used to
lengthen the window of opportunity for treating stroke patients.
More
Neural circuitry study could lead to Parkinson's insights
Zenopa
Share
A new study has uncovered fresh insights into the brain's neural circuitry which could aid understanding of the development of Parkinson's disease. The School of Science at Indiana University-Purdue University Indianapolis has created a mathematical model that examines the exchange of electrical signals within the brain when affected by the neurodegenerative condition.
More
Research advances understanding of nerve cell death in Alzheimer's
Alzheimer's Society
Share
Scientists have moved forward in their understanding of how nerve cells are killed during Alzheimer's disease, according to research published in the Journal of Neuroscience.
More
US advisers urge FDA to address antipsychotics in kids
Reuters
Share
U.S. pediatric health advisers urged drug regulators to continue studying weight gain and other side-effects of antipsychotic drugs as they are increasingly taken by children. Significant numbers of
U.S. children are receiving drugs to tame aggression, attention deficit disorder and other mental problems, even though there is little conclusive data to show exactly how the medications work or whether they damage kids' health.
More
Nurse panel reviews opioid analgesic guidelines
Nurse.com
Share
Efforts to effectively control pain in hospitalized patients with opioid analgesics can lead to unintentional sedation and respiratory depression. These unintended consequences may be avoided with
individualized patient care plans, safe administration of these drugs and appropriate monitoring practices, reported Rosemary C. Polomano, RN, PhD, an associate professor at the University of Pennsylvania School of Nursing, and her colleagues on a panel appointed by the American Society for Pain Management Nursing.
More |
|
|
Mobile version